Healthcare Sector

Revamped medical device PLI to boost localisation, widen manufacturing base

Revised scheme brings component makers and MSMEs into the incentive framework, with higher incentives for critical components and high-end devices to deepen localisation

Medical device PLI scheme extended by 8 years; focus shifts to components

The revised scheme removes the minimum sales threshold, lowers investment requirements and offers higher incentives for critical components and advanced medical devices

CCI approves Advent's ₹3,150-crore investment in Yatharth Hospitals

The US private equity firm will acquire a 24.9 per cent stake in Yatharth Hospitals through a primary capital infusion, supporting its plans to expand capacity beyond 5,000 beds.

Rainbow Children's Medicare plans ₹2,200 crore expansion by FY32

Hospital chain targets over 5,000 beds by FY32; will have more facilities in Mumbai

Fortis Q2 net profit falls 2.5% on higher expenses, lower exceptional gain

Fortis Healthcare's Q2FY27 net profit declined to ₹320 crore as expenses rose, while revenue grew 17 per cent to ₹2,735 crore, driven by hospitals and diagnostics

Glenmark Pharma Q2FY27 results: Net profit falls 57% to ₹264 crore

Consolidated revenue declined 29.8 per cent to ₹4,247 crore from ₹6,047 crore in Q2FY26

Govt proposes immediate licence suspension for substandard drugmakers

The Health Ministry has proposed suspending manufacturing licences immediately after drugs fail critical quality tests, aiming to prevent unsafe medicines from remaining in circulation.

Hospital chains urge Centre to withdraw ban on reuse of single-use devices

Hospital chains seek regulated reuse of single-use medical devices, warning that a blanket ban could raise procedure costs by 25-75% and disrupt dialysis services for nearly 500,000 patients.

India's pharma exports grow 4.9% to $16.14 bn in H1FY27 on Europe gains

India's pharmaceutical exports rose 4.9 per cent to $16.14 billion in H1FY27, driven by growth in Europe, ASEAN and Latin America, even as shipments to the US moderated.

India's pharma, healthcare deal volumes rise 23% in Q3 2026: Report

India's pharma and healthcare sector recorded 87 deals worth $4.3 billion in Q3 2026, as private equity activity surged and public market fundraising gained momentum.

CDSCO asks states, UTs to mandate raw material tests for drugmakers

The drug regulator has asked states and UTs to enforce raw material testing and vendor qualification by manufacturers, following concerns over contaminated cough syrups and drug safety.

Cap on cancer drug margins may not lower patients' medical bills: Experts

Experts warn that the 30% trade-margin cap on 137 anti-cancer drugs may offer limited relief to patients as assistance programmes remain excluded from price calculations.

Mankind Pharma Q2 PAT rises 37.7% on strong domestic chronic business

The drugmaker's revenue rose 17.3 per cent to ₹4,338 crore in Q2 FY27, supported by strong demand for chronic therapies and growth in Bharat Serums and Vaccines' speciality portfolio.

Centre forms 3-member panel to review pharma marketing code, enforcement

The three-member committee will assess the effectiveness of the UCPMP, examine enforcement mechanisms and recommend measures to curb unethical pharmaceutical marketing practices

Even Healthcare raises $50 mn in Khosla Ventures-led Series B funding

The managed care company plans to open five hospitals across Bengaluru over the next six months as its valuation triples from its previous fundraise, taking total funding past $120 million.

Centre's cancer drug margin cap draws mixed response from industry, groups

The NPPA's 30% trade margin cap on 137 oncology drugs, effective November 9, has drawn support from the pharma industry, while patient groups question its impact on affordability.

Paras Health to use ₹375 cr from IPO to pare debt, plans 800-bed expansion

The ₹1,450-crore IPO comprises a ₹500-crore fresh issue and a ₹950-crore offer for sale, while the hospital chain plans to add 800 beds through projects in Gurugram and Ludhiana

Centre directs states, UTs to display health service charges at all clinics

Union Health Ministry seeks prominent display of healthcare service charges and package rates for foreign patients travelling to India on medical or Ayush visas to improve transparency.

SC asks why drug price caps cannot extend beyond cancer medicines

Bench questions steep mark-ups on medicines and medical devices; Centre says price regulation must balance affordability with availability

Govt submits proposal to cap trade margins on anti-cancer drugs at 30%

The move could bring down the MRPs of cancer medicines by up to 70 per cent and save consumers an estimated ₹2,500 crore annually